SUMMARY
Transgenic mice with cardiac-directed C1C2, a fusion protein of the intracellular C1 and C2 segments of adenylyl cyclase type 6, had normal left ventricular (LV) function, but diminished cAMP generation. Cardiac myocytes from C1C2 mice showed increased Ca 2þ release. Mice underwent continuous isoproterenol infusion to stress the heart. In C1C2 mice, sustained isoproterenol infusion increased rather than decreased LV function. LV SERCA2a and Ca 2þ release were increased. Reduced cAMP generation and resistance to cate- These beneficial effects, consistent in several species and models, appear in large part to not depend upon increased cAMP generation. A phase 2 randomized clinical trial in patients with symptomatic heart failure (HF) and reduced ejection fractions showed that intracoronary AC6 gene transfer appears to be safe and potentially effective, and not associated with increased cardiac arrhythmias (12) .
Even so, there may be advantages in selecting a transgene that attenuates bAR responsiveness when treating HF.
We subsequently generated a catalytically inactive Eliminating the amino terminus and the 2 transmembrane domains of AC6 and subsequently fusing the 2 cytoplasmic domains (C1 and C2) with a 12-amino acid linker yields a C1C2 protein ( Figure 1A ).
C1C2 has an intact catalytic domain but is disengaged from membrane-associated bARs and is therefore less responsive to bAR stimulation in intact cells. C1C2 is sufficiently small to be inserted in an AAV vector with Gao et al.
Cardiac Effects of C1C2 D E C E M B E R 2 0 1 6 : 6 1 7 - indicate that C1C2 and AC6 expression were associated with similar increases in phosphorylation of Akt, GSK3a/b, MDM2, and p70S6k, suggesting that the effect does not require AC6-mediated cAMP production. (G) C1C2 expression was associated with phosphorylation of ERK1/2, p38 MAPK, and aB-crystallin (CryAB, upper). Interaction of CryAB and C1C2 detected by co-immunoprecipitation and immunoblotting (lower).
In A to E, Con denotes transgene negative mice. Iso ¼ isoproterenol; NRCM ¼ neonatal rat cardiac myocytes.
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Cardiac Effects of C1C2 a regulated expression cassette, enabling turning off transgene expression when desired. Many of the beneficial effects of AC6 that we have described are independent of cAMP generation and appear, instead, to involve intracellular AC6-protein interactions (10, 13) . We speculated that elimination of the transmembrane regions of AC6 ( Figure 1A) Figure 1A .
The C-terminus of C1C2 was linked with an AU1 epitope tag (DTYRYI) to facilitate detection. 
ECHOCARDIOGRAPHY.
Echocardiography was performed prior to isoproterenol (Iso) infusion and on day 6 or 7 of sustained Iso infusion, using methods previously described (15) . Anesthesia was induced with 5% isoflurane (at a flow rate of 1 L/min oxygen) and maintained with 1% isoflurane in oxygen. CARDIAC MYOCYTE ISOLATION. Cardiac myocytes were isolated as previously described (15, 16) .
were measured from cardiac myocytes isolated from transgenic mice as previously described (13, 17) .
CYCLIC AMP MEASUREMENT AND PKA ACTIVITY ASSAY. Isolated cardiac myocytes were stimulated with Iso (10 mM, 10 min) or the water-soluble forskolin analog NKH477 (10 mM, 10 min). Cyclic AMP was measured using the cAMP Biotrak EIA (GE Healthcare, Chalfont, United Kingdom) as previously reported (15) . PKA activity was determined as previously described (17) .
IMMUNOFLUORESCENCE. Isolated cardiac myocytes were attached to laminin-coated 2-well chamber slides for 1 h, washed, fixed (10% formalin, 15 min, 23 C), blocked with normal goat serum (1 h), and incubated (4 C, overnight) with the following
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antibodies: anti-AU1 antibody ( A k t s i g n a l i n g . Adenovirus-mediated gene transfer of C1C2 or AC6 into cultured cardiac myocytes was Gao et al. À4,362 AE 248 mm Hg/s, n ¼ 13; p ¼ 0.27) ( Table 2 ).
In addition, there were no differences in LV peak þdP/dt, LV peak ÀdP/dt, LV developed pressure or heart rate through a wide range of brief graded doses of infused Iso ( Figure 2D) . No baseline between-group differences were seen in LV developed pressure or heart rate ( Table 2 ).
In contrast, continuous Iso infusion showed a directionally opposite effect on LV function in mice with cardiac-directed C1C2 expression, with increases in both LV peak þdP/dt (23% increase, p ¼ 0.026) and LV peak ÀdP/dt (27% increase; p ¼ 0.006) ( Figures 3A and   3B , Table 2 ). In addition, Con mice showed reduced (p ¼ 0.012) but C1C2 mice showed increased LV developed pressure (p ¼ 0.016) ( Figure 3C ) at similar heart rates ( Figure 3D) .
NECROPSY. Table 3 shows that sustained Iso infusion was associated with similar increases in LV and liver weight in both groups.
HISTOLOGY. Histological inspection showed normal morphology without group differences in fibrosis of C1C2 mice compared to control mice at 8 months of age ( Figure 2E ). LV samples showed increased LV fibrosis (p ¼ 0.02) in control mice (but not C1C2 mice) after 7 days of continuous Iso infusion ( Figure 3E ).
CYCLIC AMP GENERATION AND PKA ACTIVITY.
Before sustained Iso infusion, transmural LV samples showed no group differences (C1C2 vs. control mice) in basal cAMP, but Iso-stimulated cAMP production was reduced in LV samples from C1C2 mice ( Figure 2B ). Stimulation of cAMP by NKH477, a forskolin analog that directly activates AC, showed no group differences ( Figure 2B ). LV PKA activity in response to brief Iso or AC stimulation with NKH477
showed no group differences ( Figure 2B ). Cardiacdirected expression of C1C2 did not alter mRNA expression of AC3, AC4, AC5, AC6, AC7, AC8, or AC9.
AC isoform expression ranged from a 14% increase (AC6) to a 13% decrease (AC7), but none was statistically significant. LV ¼ left ventricle; other abbreviations as in Table 1 .
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Gao et al. After sustained isoproterenol infusion. After 7 days of Iso infusion, C1C2 expression was associated with increased peak Ca 2þ release ( Figures 5A and 5B ) and more rapid Ca 2þ rise and decline ( Figures 5C and 5D ).
The LV SERCA2a protein expression showed no group differences prior to sustained Iso infusion. However, after 7 days of Iso infusion, LV samples from C1C2 mice showed a 2.6-fold increase in SERCA2a protein Tables 1 and 2 .
Cardiac Effects of C1C2 D E C E M B E R 2 0 1 6 : 6 1 7 -2 9 content compared to control mice (p ¼ 0.002) ( Figure 5E ). In vivo expression of C1C2 increased expression of P-Rex2 mRNA by 11.5-fold (p ¼ 0.001) ( Figure 5F ), which remained 7.5-fold increased versus control after sustained Iso infusion (p ¼ 0.0002) ( Figure 5F ). Expression or phosphorylation of other signaling proteins that modulate intracellular Ca 2þ transients (S100A1, PLB, TnI) were not altered in C1C2
LV either before ( Figure 4F ) or after 7 days of Iso ( Figure 5G ).
DISCUSSION
The most important finding of this study is that, in mice with cardiac-directed expression of C1C2, sus- Gao et al.
( Figures 3A and 3B , Table 2 ). In normal animals, the stress of 7 days of Iso was associated with a propensity for both measurements to decline. The beneficial physiological changes seen in C1C2 mice were associated with increases in rates of Ca 2þ release and decline in cardiac myocytes from C1C2 mice ( Figures 5A to 5D ).
Also seen was a 2.6-fold increase in LV SERCA2a content ( Figure 5E ), which likely was of mechanistic importance in the enhancement of Ca 2þ handling.
Indeed, other studies have reported that cardiacdirected expression of SERCA2a increases Ca 2þ transient amplitude (23) . If these effects were also to occur in clinical settings, one would predict protection of the heart against sustained catecholamine stimulation, a common feature of clinical HF, and one thought to be responsible, at least in part, for the inexorable decline of cardiac function frequently seen in HF.
However, increased Ca 2þ uptake and release were seen in cardiac myocytes from C1C2 animals prior to 7
days of Iso infusion ( Figures 4C and 4D ), even though LV SERCA2a content was unchanged ( Figure 5E , left).
However, there were no group differences in Tau before ( Figure 4E ) but improved Tau after 7 days of Iso infusion ( Figure 5D ), which correlated well with LV SERCA2a content, which had increased after Iso infusion ( Figure 5E , right). C1C2 expression is associated with changes in multiple intracellular events aside from SERCA2a, including an 11.5-fold increase in LV expression of P-Rex2 ( Figure 5F ). P-Rex2 inhibits the activity of phosphatase and tensin homolog (PTEN), which increases Akt activation (24) . PTEN deletion increases cardiac L-type Ca 2þ currents via increased Akt activation (25) . Increased P-Rex2 expression and subsequent Akt activation would be predicted to increase Ca 2þ uptake and release in cardiac myocytes. handling will require additional studies.
Why was the increase in LV peak þdP/dt in the C1C2 mice after sustained Iso infusion ( Figure 3A ) not also seen in LV fractional shortening in the echocardiographic studies ( Table 1) C1C2 influences other intracellular signaling pathways such as CryAB, Akt, ERK1/2 and p38 MAPK pathways ( Figures 1F and 1G) . We do not know the precise pathway by which C1C2 affects intracellular signaling and protein expression and phosphorylation. C1C2 interacts with G-protein coupled receptors, Gas, Gbg and A-kinase anchoring proteins (AKAPs), and could thereby influence intracellular signaling.
Previous studies indicate that the C1C2 portion of AC6 enables AC6 targeting to lipid rafts (14) .
C1C2 expression was associated with increased LV PRex2 expression detected by gene array and confirmed by RT-PCR ( Figure 5F ). P-Rex2 inhibits the activity of PTEN and increases Akt activation (24) . Activation of Akt signaling pathways by C1C2 was detected in cultured cardiac myocytes after Ad5.C1C2 gene transfer ( Figure 1F) , which was quantitatively similar to effects seen with AC6. In previous studies we established that this is one of the mechanisms by which AC6 expression has beneficial effects on cardiac function (21) . C1C2 mimics this property of AC6, confirming the mechanism does not require increased LV cAMP.
C1C2 expression increased phosphorylation of
CryAB at S45 and S59 sites and C1C2 protein, based on co-immunoprecipitation, is physically associated with CryAB ( Figure 1G ). CryAB, a member of the small heat shock protein (HSPs) family, is expressed at high levels in cardiac myocytes, and its expression protects against ischemia-reperfusion injury (27) . The role of CryAB-C1C2 association will require additional studies, but it underscores the importance that protein-protein interactions play in mechanisms by which C1C2 affects cardiac function. The study of C1C2-interacting proteins is a focus of study in our laboratory.
STUDY LIMITATIONS. Because of the complexity of multiple signaling pathways that are relevant in the failing heart, no single study can establish precise molecular pathways for every favorable adaptation.
Despite this generic limitation, it is encouraging that cardiac-directed expression of C1C2 has a favorable impact on function of the intact heart in the setting of conditions that mimic aspects of clinical heart failure.
The present study examines Iso-stimulated cardiomyopathy only at 7 days, and it remains to be seen whether these protective effects of C1C2 will persist for longer periods and in other models of heart failure.
CONCLUSIONS
Increased expression of C1C2 in cardiac myocytes and heart mimics some of the beneficial cardiac effects of AC6. C1C2 enhances Ca 2þ handling, which is of mechanistic importance in its beneficial effects. Sus- Cardiac Effects of C1C2 D E C E M B E R 2 0 1 6 : 6 1 7 -2 9
